Overrepresented syndromic features identified in JAK1 variant-positive individuals by blinded systematic review of EHRsa
| Odds ratio (95% CI) | P value (Fisher’s exact) | Variant positive (n = 43) | Variant negative (n = 129) | |
|---|---|---|---|---|
| Sex (female) | 1.098 (0.5504–2.204) | 0.8609 | 22 | 63 |
| Autoimmunity | 2.203 (1.066–4.551) | 0.0412* | 21 | 39 |
| Hashimoto thyroiditis | 9.600 (1.377–125.4) | 0.0487* | 3 | 1 |
| Rheumatic disease | 8.355 (1.659–42.67) | 0.0112* | 5 | 2 |
| Autoimmunity and ≥ any one category | 2.335 (1.106–4.880) | 0.0235* | 20 | 35 |
| Autoimmunity and ≥ any two categories | 2.47 (1.167–5.044) | 0.0252* | 17 | 27 |
| Atopy | 1.499 (0.7531–3.050) | 0.2908 | 23 | 56 |
| Atopy and ≥ any one category | 1.665 (0.8196–3.372) | 0.1553 | 21 | 47 |
| Atopy and ≥ any two categories | 2.183 (1.074–4.626) | 0.0513 | 18 | 32 |
| Colitis (GI inflammation) | 1.499 (0.7554–3.083) | 0.2922 | 24 | 59 |
| Colitis and ≥ any one category | 1.649 (0.8265–3.365) | 0.1619 | 23 | 53 |
| Colitis and ≥ any two categories | 2.43 (1.147–5.101) | 0.0219* | 20 | 34 |
| Dermatitis | 1.323 (0.6304–2.701) | 0.5798 | 30 | 82 |
| Dermatitis and ≥ any one category | 1.675 (0.8299–3.466) | 0.2143 | 28 | 68 |
| Dermatitis and ≥ any two categories | 2.559 (1.256–5.011) | 0.0105* | 23 | 40 |
| Any 3+ categories (autoimmunity, atopy, colitis, or dermatitis) | 2.559 (1.256–5.011) | 0.0105* | 23 | 40 |
| Odds ratio (95% CI) | P value (Fisher’s exact) | Variant positive ( | Variant negative ( | |
|---|---|---|---|---|
| Sex (female) | 1.098 (0.5504–2.204) | 0.8609 | 22 | 63 |
| Autoimmunity | 2.203 (1.066–4.551) | 0.0412* | 21 | 39 |
| Hashimoto thyroiditis | 9.600 (1.377–125.4) | 0.0487* | 3 | 1 |
| Rheumatic disease | 8.355 (1.659–42.67) | 0.0112* | 5 | 2 |
| Autoimmunity and ≥ any one category | 2.335 (1.106–4.880) | 0.0235* | 20 | 35 |
| Autoimmunity and ≥ any two categories | 2.47 (1.167–5.044) | 0.0252* | 17 | 27 |
| Atopy | 1.499 (0.7531–3.050) | 0.2908 | 23 | 56 |
| Atopy and ≥ any one category | 1.665 (0.8196–3.372) | 0.1553 | 21 | 47 |
| Atopy and ≥ any two categories | 2.183 (1.074–4.626) | 0.0513 | 18 | 32 |
| Colitis (GI inflammation) | 1.499 (0.7554–3.083) | 0.2922 | 24 | 59 |
| Colitis and ≥ any one category | 1.649 (0.8265–3.365) | 0.1619 | 23 | 53 |
| Colitis and ≥ any two categories | 2.43 (1.147–5.101) | 0.0219* | 20 | 34 |
| Dermatitis | 1.323 (0.6304–2.701) | 0.5798 | 30 | 82 |
| Dermatitis and ≥ any one category | 1.675 (0.8299–3.466) | 0.2143 | 28 | 68 |
| Dermatitis and ≥ any two categories | 2.559 (1.256–5.011) | 0.0105* | 23 | 40 |
| Any 3+ categories (autoimmunity, atopy, colitis, or dermatitis) | 2.559 (1.256–5.011) | 0.0105* | 23 | 40 |
Odds ratios with 95% confidence interval (CI) generated using Baptista Pike method. P values generated using Fisher’s exact test (two-tailed) test. P values <0.05 are indicated by an asterisk (*). Variant-positive and variant-negative columns indicate the number of EHRs with at least one finding present for each row.
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.